| 1 |
Stephen John Atkinson |
Glaxosmithkline Intellectual Property (No. 4) Limited |
5 |
| 2 |
Alexander G. Preston |
Glaxosmithkline Intellectual Property (No. 4) Limited |
4 |
| 2 |
Agostino Marasco |
Autifony Therapeutics Limited |
4 |
| 2 |
Jonathan Thomas Seal |
Glaxosmithkline Intellectual Property (No. 4) Limited |
4 |
| 2 |
Giuseppe Alvaro |
Autifony Therapeutics Limited |
4 |
| 2 |
Michael David Woodrow |
Mission Therapeutics Limited |
4 |
| 2 |
Lee Andrew Harrison |
Glaxosmithkline Intellectual Property (No. 4) Limited |
4 |
| #8 |
Anne Goubier |
Cancer Research Technology Limited |
3 |
| #8 |
Josephine Salimu |
Cancer Research Technology Limited |
3 |
| #8 |
Ian David Wall |
Glaxosmithkline Intellectual Property (No. 4) Limited |
3 |
| #8 |
Emmanuel Hubert Demont |
Glaxosmithkline Intellectual Property (No. 4) Limited |
3 |
| #8 |
Kevin Moulder |
Cancer Research Technology Limited |
3 |
| #8 |
James Michael Woolven |
Glaxosmithkline Intellectual Property (No. 4) Limited |
3 |
| #8 |
Beatriz Goyenechea Corzo |
Cancer Research Technology Limited |
3 |
| #8 |
Pascal Merchiers |
Cancer Research Technology Limited |
3 |
| #16 |
Alan Peter Lewis |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #16 |
Afjal Hussain Miah |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #16 |
John David Harling |
Smithkline Beeacham P.L.C. |
2 |
| #16 |
Gemma Victoria White |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #16 |
Kevin Alan Neil Aylward |
Rakon Limited |
2 |
| #16 |
Dominique Amans |
Glaxosmithkline |
2 |
| #16 |
John Liddle |
Glaxo Group Limited |
2 |
| #16 |
Ann Louise Walker |
Glaxo Group Limited |
2 |
| #16 |
Tim Forshew |
Inivata |
2 |
| #16 |
Tomoaki KURAKAZU |
Asahi Rubber |
2 |
| #16 |
Joelle Le |
Glaxo Group Limited |
2 |
| #16 |
Christopher Roland Wellaway |
Glaxosmithkline Intellectual Property (No. 4) Limited |
2 |
| #16 |
Etienne Levernier |
Glaxosmithkline Intellectual Property (No. 4) Limited |
2 |
| #16 |
Niall Andrew Anderson |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #16 |
Julie Nicole Hamblin |
Glaxo Group Limited |
2 |
| #16 |
Terence Alan Ackerman |
Mbda Uk Limited |
2 |
| #16 |
Andrew Robert Pacey |
Limflow Gmbh |
2 |
| #16 |
Ian Edward David Smith |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #34 |
Gabriel Pemberton |
University Court Of The University Of Glasgow |
1 |
| #34 |
Robert Peter Law |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #34 |
Matthew Lindon |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #34 |
Stephen Mclaren |
Airbus Defence And Space Gmbh |
1 |
| #34 |
Suzanne Elaine Keeling |
Glaxo Group Limited |
1 |
| #34 |
Nicholas Paul Henley |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Jonathan Henry Ellis |
Glaxo Group Limited |
1 |
| #34 |
Vipulkumar Kantibhai Patel |
Smithkline Beecham Limited |
1 |
| #34 |
Susannah Karen Ford |
Glaxo Group Limited |
1 |
| #34 |
Maria Feeney |
Glaxo Group Limited |
1 |
| #34 |
Gary Peter Bembridge |
Glaxo Group Limited |
1 |
| #34 |
Armelle Le Gall |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Edward Paul Cannons |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Hawa Diallo |
Glaxo Group Limited |
1 |
| #34 |
Robert John Sheppard |
Glaxo Group Limited |
1 |
| #34 |
Anthony William Dean |
Glaxo Group Limited |
1 |
| #34 |
Simon Peace |
Glaxosmithkline Intellectual Property Development Limited |
1 |